HCW Biologics Inc. (NASDAQ: HCWB) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT HCW BIOLOGICS INC.

HCW Biologics Inc. (NASDAQ: HCWB)
Listen to this Section


$1.65
+0.0150 ( +0.92% ) 476.2K

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Clinical Trial Pipeline Stages


Drug Name Stage
HCW9218DetailsCancer, Solid tumor/s, Ovarian cancer Phase 2
HCW9218DetailsSolid tumor/s, Pancreatic cancer, Cancer Phase 1/2

Market Data


Open $1.65
Previous Close $1.63
Volume 476.2K
Market Cap $12.03M
Day Range $1.55 - $1.69
52 Week Range $0.25 - $7.35
Shares Outstanding 7.16M
Change % +0.92%
Net Change ▲ 0.0150
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2021
CountryUnited States
UnderwriterEF Hutton, Revere Securities, more

Insider Ownership Transactions

Total Amount Purchased: -1,763,369.00

Date Type Amount Purchased Purchaser
2025-05-20 Buy 8054.00 Wong Hing C
2025-05-20 Buy 13423.00 GARRETT SCOTT T
2025-05-20 Buy 1342.00 Winer Gary M
2025-05-09 Buy 2308.00 Winer Gary M
2025-05-09 Buy 5385.00 GARRETT SCOTT T
2025-05-09 Buy 962.00 Greene Rick S.
2025-05-09 Buy 962.00 Flowers Lee
2025-05-09 Buy 8462.00 Byam Rebecca
2025-05-09 Buy 92500.00 Wong Hing C
2024-06-17 Sale -12500.00 GARRETT SCOTT T

SEC Filings


Form Type Description Pages Date
8-k 8K-related 10 Jul 18, 2025
8-k 8K-related 10 Jul 01, 2025
8-k 8K-related 12 Jun 26, 2025
8-k 8K-related 12 Jun 23, 2025
8-k 8K-related 10 Jun 13, 2025
8-k 8K-related 14 Jun 05, 2025
8-k 8K-related 12 Jun 04, 2025

Latest News


× Before browsing our site, please accept our cookies policy